世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gene Therapy For Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2518 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Rb遺伝子、P53遺伝子、APC遺伝子、NF1遺伝子、その他）、用途別市場規模（がん治療、組織修復、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・がん遺伝子治療の種類別市場規模（Rb遺伝子、P53遺伝子、APC遺伝子、NF1遺伝子、その他） ・がん遺伝子治療の用途別市場規模（がん治療、組織修復、その他） ・がん遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・がん遺伝子治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GLIEAD、REGENXBIO、Autolus、American Gene Technologies、Arcellx、AUSTRIANOVA、Alphavax、Cellectis、Chimeron） ・結論

Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.

Market Analysis and Insights: Global Gene Therapy For Cancer Market
The global Gene Therapy For Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy For Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy For Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy For Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy For Cancer market.

Global Gene Therapy For Cancer Scope and Market Size
Gene Therapy For Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy For Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Rb Gene
P53 Gene
APC Gene
NF1 Gene
Others

Segment by Application
Cancer Treatment
Tissue Repair
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GLIEAD
REGENXBIO
Autolus
American Gene Technologies
Arcellx
AUSTRIANOVA
Alphavax

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy For Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rb Gene
1.2.3 P53 Gene
1.2.4 APC Gene
1.2.5 NF1 Gene
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy For Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Treatment
1.3.3 Tissue Repair
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy For Cancer Market Perspective (2016-2027)
2.2 Gene Therapy For Cancer Growth Trends by Regions
2.2.1 Gene Therapy For Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy For Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy For Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy For Cancer Industry Dynamic
2.3.1 Gene Therapy For Cancer Market Trends
2.3.2 Gene Therapy For Cancer Market Drivers
2.3.3 Gene Therapy For Cancer Market Challenges
2.3.4 Gene Therapy For Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy For Cancer Players by Revenue
3.1.1 Global Top Gene Therapy For Cancer Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy For Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy For Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy For Cancer Revenue
3.4 Global Gene Therapy For Cancer Market Concentration Ratio
3.4.1 Global Gene Therapy For Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Cancer Revenue in 2020
3.5 Gene Therapy For Cancer Key Players Head office and Area Served
3.6 Key Players Gene Therapy For Cancer Product Solution and Service
3.7 Date of Enter into Gene Therapy For Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy For Cancer Breakdown Data by Type
4.1 Global Gene Therapy For Cancer Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy For Cancer Forecasted Market Size by Type (2022-2027)

5 Gene Therapy For Cancer Breakdown Data by Application
5.1 Global Gene Therapy For Cancer Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy For Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Therapy For Cancer Market Size (2016-2027)
6.2 North America Gene Therapy For Cancer Market Size by Type
6.2.1 North America Gene Therapy For Cancer Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy For Cancer Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy For Cancer Market Size by Type (2016-2027)
6.3 North America Gene Therapy For Cancer Market Size by Application
6.3.1 North America Gene Therapy For Cancer Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy For Cancer Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy For Cancer Market Size by Application (2016-2027)
6.4 North America Gene Therapy For Cancer Market Size by Country
6.4.1 North America Gene Therapy For Cancer Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy For Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gene Therapy For Cancer Market Size (2016-2027)
7.2 Europe Gene Therapy For Cancer Market Size by Type
7.2.1 Europe Gene Therapy For Cancer Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy For Cancer Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy For Cancer Market Size by Type (2016-2027)
7.3 Europe Gene Therapy For Cancer Market Size by Application
7.3.1 Europe Gene Therapy For Cancer Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy For Cancer Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy For Cancer Market Size by Application (2016-2027)
7.4 Europe Gene Therapy For Cancer Market Size by Country
7.4.1 Europe Gene Therapy For Cancer Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy For Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy For Cancer Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy For Cancer Market Size by Type
8.2.1 Asia-Pacific Gene Therapy For Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy For Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy For Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy For Cancer Market Size by Application
8.3.1 Asia-Pacific Gene Therapy For Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy For Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy For Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy For Cancer Market Size by Region
8.4.1 Asia-Pacific Gene Therapy For Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy For Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Therapy For Cancer Market Size (2016-2027)
9.2 Latin America Gene Therapy For Cancer Market Size by Type
9.2.1 Latin America Gene Therapy For Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy For Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy For Cancer Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy For Cancer Market Size by Application
9.3.1 Latin America Gene Therapy For Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy For Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy For Cancer Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy For Cancer Market Size by Country
9.4.1 Latin America Gene Therapy For Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy For Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy For Cancer Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy For Cancer Market Size by Type
10.2.1 Middle East & Africa Gene Therapy For Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy For Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy For Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy For Cancer Market Size by Application
10.3.1 Middle East & Africa Gene Therapy For Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy For Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy For Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy For Cancer Market Size by Country
10.4.1 Middle East & Africa Gene Therapy For Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy For Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GLIEAD
11.1.1 GLIEAD Company Details
11.1.2 GLIEAD Business Overview
11.1.3 GLIEAD Gene Therapy For Cancer Introduction
11.1.4 GLIEAD Revenue in Gene Therapy For Cancer Business (2016-2021)
11.1.5 GLIEAD Recent Development
11.2 REGENXBIO
11.2.1 REGENXBIO Company Details
11.2.2 REGENXBIO Business Overview
11.2.3 REGENXBIO Gene Therapy For Cancer Introduction
11.2.4 REGENXBIO Revenue in Gene Therapy For Cancer Business (2016-2021)
11.2.5 REGENXBIO Recent Development
11.3 Autolus
11.3.1 Autolus Company Details
11.3.2 Autolus Business Overview
11.3.3 Autolus Gene Therapy For Cancer Introduction
11.3.4 Autolus Revenue in Gene Therapy For Cancer Business (2016-2021)
11.3.5 Autolus Recent Development
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Details
11.4.2 American Gene Technologies Business Overview
11.4.3 American Gene Technologies Gene Therapy For Cancer Introduction
11.4.4 American Gene Technologies Revenue in Gene Therapy For Cancer Business (2016-2021)
11.4.5 American Gene Technologies Recent Development
11.5 Arcellx
11.5.1 Arcellx Company Details
11.5.2 Arcellx Business Overview
11.5.3 Arcellx Gene Therapy For Cancer Introduction
11.5.4 Arcellx Revenue in Gene Therapy For Cancer Business (2016-2021)
11.5.5 Arcellx Recent Development
11.6 AUSTRIANOVA
11.6.1 AUSTRIANOVA Company Details
11.6.2 AUSTRIANOVA Business Overview
11.6.3 AUSTRIANOVA Gene Therapy For Cancer Introduction
11.6.4 AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2016-2021)
11.6.5 AUSTRIANOVA Recent Development
11.7 Alphavax
11.7.1 Alphavax Company Details
11.7.2 Alphavax Business Overview
11.7.3 Alphavax Gene Therapy For Cancer Introduction
11.7.4 Alphavax Revenue in Gene Therapy For Cancer Business (2016-2021)
11.7.5 Alphavax Recent Development
11.8 Cellectis
11.8.1 Cellectis Company Details
11.8.2 Cellectis Business Overview
11.8.3 Cellectis Gene Therapy For Cancer Introduction
11.8.4 Cellectis Revenue in Gene Therapy For Cancer Business (2016-2021)
11.8.5 Cellectis Recent Development
11.9 Chimeron
11.9.1 Chimeron Company Details
11.9.2 Chimeron Business Overview
11.9.3 Chimeron Gene Therapy For Cancer Introduction
11.9.4 Chimeron Revenue in Gene Therapy For Cancer Business (2016-2021)
11.9.5 Chimeron Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene Therapy For Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rb Gene
Table 3. Key Players of P53 Gene
Table 4. Key Players of APC Gene
Table 5. Key Players of NF1 Gene
Table 6. Key Players of Others
Table 7. Global Gene Therapy For Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gene Therapy For Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Gene Therapy For Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Gene Therapy For Cancer Market Share by Regions (2016-2021)
Table 11. Global Gene Therapy For Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Gene Therapy For Cancer Market Share by Regions (2022-2027)
Table 13. Gene Therapy For Cancer Market Trends
Table 14. Gene Therapy For Cancer Market Drivers
Table 15. Gene Therapy For Cancer Market Challenges
Table 16. Gene Therapy For Cancer Market Restraints
Table 17. Global Gene Therapy For Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Gene Therapy For Cancer Market Share by Players (2016-2021)
Table 19. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy For Cancer as of 2020)
Table 20. Ranking of Global Top Gene Therapy For Cancer Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Gene Therapy For Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gene Therapy For Cancer Product Solution and Service
Table 24. Date of Enter into Gene Therapy For Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Therapy For Cancer Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Gene Therapy For Cancer Revenue Market Share by Type (2016-2021)
Table 28. Global Gene Therapy For Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Gene Therapy For Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Gene Therapy For Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Gene Therapy For Cancer Revenue Market Share by Application (2016-2021)
Table 32. Global Gene Therapy For Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Gene Therapy For Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Gene Therapy For Cancer Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Gene Therapy For Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Gene Therapy For Cancer Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Gene Therapy For Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Gene Therapy For Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Gene Therapy For Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Gene Therapy For Cancer Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Gene Therapy For Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Gene Therapy For Cancer Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Gene Therapy For Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Gene Therapy For Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Gene Therapy For Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Therapy For Cancer Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Therapy For Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy For Cancer Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Gene Therapy For Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Gene Therapy For Cancer Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Gene Therapy For Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Gene Therapy For Cancer Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Gene Therapy For Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Gene Therapy For Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Gene Therapy For Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Therapy For Cancer Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Therapy For Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy For Cancer Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Gene Therapy For Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 64. GLIEAD Company Details
Table 65. GLIEAD Business Overview
Table 66. GLIEAD Gene Therapy For Cancer Product
Table 67. GLIEAD Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 68. GLIEAD Recent Development
Table 69. REGENXBIO Company Details
Table 70. REGENXBIO Business Overview
Table 71. REGENXBIO Gene Therapy For Cancer Product
Table 72. REGENXBIO Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 73. REGENXBIO Recent Development
Table 74. Autolus Company Details
Table 75. Autolus Business Overview
Table 76. Autolus Gene Therapy For Cancer Product
Table 77. Autolus Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 78. Autolus Recent Development
Table 79. American Gene Technologies Company Details
Table 80. American Gene Technologies Business Overview
Table 81. American Gene Technologies Gene Therapy For Cancer Product
Table 82. American Gene Technologies Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 83. American Gene Technologies Recent Development
Table 84. Arcellx Company Details
Table 85. Arcellx Business Overview
Table 86. Arcellx Gene Therapy For Cancer Product
Table 87. Arcellx Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 88. Arcellx Recent Development
Table 89. AUSTRIANOVA Company Details
Table 90. AUSTRIANOVA Business Overview
Table 91. AUSTRIANOVA Gene Therapy For Cancer Product
Table 92. AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 93. AUSTRIANOVA Recent Development
Table 94. Alphavax Company Details
Table 95. Alphavax Business Overview
Table 96. Alphavax Gene Therapy For Cancer Product
Table 97. Alphavax Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 98. Alphavax Recent Development
Table 99. Cellectis Company Details
Table 100. Cellectis Business Overview
Table 101. Cellectis Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 102. Cellectis Recent Development
Table 103. Chimeron Company Details
Table 104. Chimeron Business Overview
Table 105. Chimeron Gene Therapy For Cancer Product
Table 106. Chimeron Revenue in Gene Therapy For Cancer Business (2016-2021) & (US$ Million)
Table 107. Chimeron Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy For Cancer Market Share by Type: 2020 VS 2027
Figure 2. Rb Gene Features
Figure 3. P53 Gene Features
Figure 4. APC Gene Features
Figure 5. NF1 Gene Features
Figure 6. Others Features
Figure 7. Global Gene Therapy For Cancer Market Share by Application: 2020 VS 2027
Figure 8. Cancer Treatment Case Studies
Figure 9. Tissue Repair Case Studies
Figure 10. Others Case Studies
Figure 11. Gene Therapy For Cancer Report Years Considered
Figure 12. Global Gene Therapy For Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Gene Therapy For Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Gene Therapy For Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Gene Therapy For Cancer Market Share by Regions (2022-2027)
Figure 16. Global Gene Therapy For Cancer Market Share by Players in 2020
Figure 17. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy For Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy For Cancer Revenue in 2020
Figure 19. Global Gene Therapy For Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Gene Therapy For Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Gene Therapy For Cancer Market Share by Type (2016-2027)
Figure 23. North America Gene Therapy For Cancer Market Share by Application (2016-2027)
Figure 24. North America Gene Therapy For Cancer Market Share by Country (2016-2027)
Figure 25. United States Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Gene Therapy For Cancer Market Share by Type (2016-2027)
Figure 29. Europe Gene Therapy For Cancer Market Share by Application (2016-2027)
Figure 30. Europe Gene Therapy For Cancer Market Share by Country (2016-2027)
Figure 31. Germany Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Gene Therapy For Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Gene Therapy For Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Gene Therapy For Cancer Market Share by Region (2016-2027)
Figure 41. China Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Gene Therapy For Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Gene Therapy For Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Gene Therapy For Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Gene Therapy For Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Gene Therapy For Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Gene Therapy For Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Gene Therapy For Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. GLIEAD Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 61. REGENXBIO Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 62. Autolus Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 63. American Gene Technologies Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 64. Arcellx Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 65. AUSTRIANOVA Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 66. Alphavax Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 67. Cellectis Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 68. Chimeron Revenue Growth Rate in Gene Therapy For Cancer Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---